In this issue:
Toripalimab + nab-paclitaxel in metastatic/recurrent TNBC
Digital histological biomarker for invasive breast cancer prognosis
Feasibility of monitoring GBCI Framework KPIs in 21 Asian countries
Cost-effectiveness of population-based multigene testing for breast/ovarian cancer prevention
Optimising first-line subtyping-based therapy in TNBC
Atezolizumab + carboplatin: survival in metastatic TNBC
Clinical and biomarker findings of neoadjuvant pembrolizumab and carboplatin + docetaxel in TNBC
CTCs for predicting survival in hormone receptor-positive, HER2-negative advanced breast cancer
Association of IGF2BP3 with tumour progression and brain-specific metastases in breast cancer
Cryotherapy vs. compression vs. placebo to prevent taxane-induced peripheral neuropathy
Please login below to download this issue (PDF)